Literature DB >> 9278454

Glomerular mesangial cell-specific transactivation of matrix metalloproteinase 2 transcription is mediated by YB-1.

P R Mertens1, S Harendza, A S Pollock, D H Lovett.   

Abstract

Mesangial cell (MC) activation plays a pivotal role in the development of the end stage sclerotic lesion characteristic of most forms of chronic glomerular disease. We have previously demonstrated that MC activation is directly linked to high level expression of the matrix metalloproteinase-2 (MMP-2) enzyme (Turck, J., Pollock, A. S., Lee, L., Marti, H.-P., and Lovett, D. H. (1996) J. Biol. Chem. 25, 15074-15083), the transcription of which is regulated in a tissue-specific fashion. Recent studies (Harendza, S., Pollock, A., Mertens, P. R., and Lovett, D. H. (1995) J. Biol. Chem. 270, 18786-18796) delineated a strong cis-acting enhancer element, designated MMP-2 RE1, within the 5'-flanking region of the rat MMP-2 gene. Gel shift, DNA footprint, and transcriptional analyses mapped the enhancer element to a unique 40-base pair (bp) sequence located at -1322 to -1282 bp relative to the translational start site. Bromodeoxyuridine-substituted UV cross-linking of the 40-bp enhancer element with MC nuclear extracts yielded a single protein of 52 kDa, while Southwestern blot analysis with MMP-2 RE1 demonstrated three hybridizing nuclear proteins of 52, 62, and 86 kDa size. Screening of a human MC cDNA expression library with MMP-2 RE1 exclusively yielded clones with the identical sequence of the transcription factor YB-1. Western blot and supershift gel analysis of MC nuclear extracts with an anti-YB-1 antibody confirmed the presence of YB-1 within the shifted complex. Examination of the MMP-2 RE1 sequence revealed an incomplete Y-box sequence (CTGCTGGGCAAG), which specifically interacted with recombinant YB-1 on DMS protection footprinting analysis. YB-1 protein preferentially bound the single-stranded components of the 40-bp MMP-2 RE1 and, with increasing concentrations, formed multimeric complexes. Co-transfection of YB-1 in MC increased the enhancer activity within the context of the native MMP-2 promoter, while transfection of non-MMP-2-synthesizing glomerular epithelial cells with YB-1 led to transcriptional suppression. This study indicates that YB-1 is a major, cell type-specific transactivator of MMP-2 transcription by glomerular mesangial cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9278454     DOI: 10.1074/jbc.272.36.22905

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

1.  Reciprocal interaction between two cellular proteins, Puralpha and YB-1, modulates transcriptional activity of JCVCY in glial cells.

Authors:  M Safak; G L Gallia; K Khalili
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

2.  Co-operative interactions between NFAT (nuclear factor of activated T cells) c1 and the zinc finger transcription factors Sp1/Sp3 and Egr-1 regulate MT1-MMP (membrane type 1 matrix metalloproteinase) transcription by glomerular mesangial cells.

Authors:  Maria Alejandra Alfonso-Jaume; Rajeev Mahimkar; David H Lovett
Journal:  Biochem J       Date:  2004-06-15       Impact factor: 3.857

3.  YB-1 alters MT1-MMP trafficking and stimulates MCF-7 breast tumor invasion and metastasis.

Authors:  David H Lovett; Sunfa Cheng; Leslie Cape; Allan S Pollock; Peter R Mertens
Journal:  Biochem Biophys Res Commun       Date:  2010-07-01       Impact factor: 3.575

4.  RBP16 stimulates trypanosome RNA editing in vitro at an early step in the editing reaction.

Authors:  Melissa M Miller; Kari Halbig; Jorge Cruz-Reyes; Laurie K Read
Journal:  RNA       Date:  2006-05-11       Impact factor: 4.942

5.  RBP16 is a multifunctional gene regulatory protein involved in editing and stabilization of specific mitochondrial mRNAs in Trypanosoma brucei.

Authors:  Michel Pelletier; Laurie K Read
Journal:  RNA       Date:  2003-04       Impact factor: 4.942

6.  YB-1 acts as a ligand for Notch-3 receptors and modulates receptor activation.

Authors:  Thomas Rauen; Ute Raffetseder; Björn C Frye; Sonja Djudjaj; Philipp J T Mühlenberg; Frank Eitner; Urban Lendahl; Jürgen Bernhagen; Steven Dooley; Peter R Mertens
Journal:  J Biol Chem       Date:  2009-07-29       Impact factor: 5.157

7.  Inhibition of protein synthesis by Y box-binding protein 1 blocks oncogenic cell transformation.

Authors:  Andreas G Bader; Peter K Vogt
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

8.  Mechanisms of matrix metalloproteinase-2 (mmp-2) transcriptional repression by progesterone in jar choriocarcinoma cells.

Authors:  Shlomit Goldman; David H Lovett; Eliezer Shalev
Journal:  Reprod Biol Endocrinol       Date:  2009-05-09       Impact factor: 5.211

Review 9.  Targeting the Y/CCAAT box in cancer: YB-1 (YBX1) or NF-Y?

Authors:  D Dolfini; R Mantovani
Journal:  Cell Death Differ       Date:  2013-03-01       Impact factor: 15.828

10.  Nuclear detection of Y-box protein-1 (YB-1) closely associates with progesterone receptor negativity and is a strong adverse survival factor in human breast cancer.

Authors:  Edgar Dahl; Abdelaziz En-Nia; Frank Wiesmann; Renate Krings; Sonja Djudjaj; Elisabeth Breuer; Thomas Fuchs; Peter J Wild; Arndt Hartmann; Sandra E Dunn; Peter R Mertens
Journal:  BMC Cancer       Date:  2009-11-24       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.